Thway K[au] - Search Results

Year	Number of Results
2000	1
2002	1
2005	1
2007	4
2008	6
2009	10
2010	16
2011	15
2012	19
2013	14
2014	26
2015	35
2016	41
2017	25
2018	20
2019	19
2020	24
2021	22
2022	5

1

Well-differentiated liposarcoma and dedifferentiated liposarcoma: An updated review.

Thway K. Thway K. Semin Diagn Pathol. 2019 Mar;36(2):112-121. doi: 10.1053/j.semdp.2019.02.006. Epub 2019 Feb 28. Semin Diagn Pathol. 2019. PMID: 30852045 Review.

2

Clinical and Molecular Spectrum of Liposarcoma.

Lee ATJ, Thway K, Huang PH, Jones RL. Lee ATJ, et al. Among authors: thway k. J Clin Oncol. 2018 Jan 10;36(2):151-159. doi: 10.1200/JCO.2017.74.9598. Epub 2017 Dec 8. J Clin Oncol. 2018. PMID: 29220294 Free PMC article. Review.

3

Synovial sarcoma: defining features and diagnostic evolution.

Thway K, Fisher C. Thway K, et al. Ann Diagn Pathol. 2014 Dec;18(6):369-80. doi: 10.1016/j.anndiagpath.2014.09.002. Epub 2014 Oct 13. Ann Diagn Pathol. 2014. PMID: 25438927 Review.

4

Dermatofibrosarcoma protuberans: pathology, genetics, and potential therapeutic strategies.

Thway K, Noujaim J, Jones RL, Fisher C. Thway K, et al. Ann Diagn Pathol. 2016 Dec;25:64-71. doi: 10.1016/j.anndiagpath.2016.09.013. Epub 2016 Sep 27. Ann Diagn Pathol. 2016. PMID: 27806849 Review.

5

PEComa: morphology and genetics of a complex tumor family.

Thway K, Fisher C. Thway K, et al. Ann Diagn Pathol. 2015 Oct;19(5):359-68. doi: 10.1016/j.anndiagpath.2015.06.003. Epub 2015 Jun 9. Ann Diagn Pathol. 2015. PMID: 26144278 Review.

6

Orally bioavailable CDK9/2 inhibitor shows mechanism-based therapeutic potential in MYCN-driven neuroblastoma.

Poon E, Liang T, Jamin Y, Walz S, Kwok C, Hakkert A, Barker K, Urban Z, Thway K, Zeid R, Hallsworth A, Box G, Ebus ME, Licciardello MP, Sbirkov Y, Lazaro G, Calton E, Costa BM, Valenti M, De Haven Brandon A, Webber H, Tardif N, Almeida GS, Christova R, Boysen G, Richards MW, Barone G, Ford A, Bayliss R, Clarke PA, De Bono J, Gray NS, Blagg J, Robinson SP, Eccles SA, Zheleva D, Bradner JE, Molenaar J, Vivanco I, Eilers M, Workman P, Lin CY, Chesler L. Poon E, et al. Among authors: thway k. J Clin Invest. 2020 Nov 2;130(11):5875-5892. doi: 10.1172/JCI134132. J Clin Invest. 2020. PMID: 33016930 Free PMC article.

7

Dose Reduction of Preoperative Radiotherapy in Myxoid Liposarcoma: A Nonrandomized Controlled Trial.

Lansu J, Bovée JVMG, Braam P, van Boven H, Flucke U, Bonenkamp JJ, Miah AB, Zaidi SH, Thway K, Bruland ØS, Baldini EH, Jebsen NL, Scholten AN, van den Ende PLA, Krol ADG, Ubbels JF, van der Hage JA, van Werkhoven E, Klomp HM, van der Graaf WTA, van Coevorden F, Schrage Y, van Houdt WJ, Haas RL. Lansu J, et al. Among authors: thway k. JAMA Oncol. 2021 Jan 1;7(1):e205865. doi: 10.1001/jamaoncol.2020.5865. Epub 2021 Jan 21. JAMA Oncol. 2021. PMID: 33180100 Free PMC article. Clinical Trial.

8

Desmoid-type fibromatosis.

Otero S, Moskovic EC, Strauss DC, Benson C, Miah AB, Thway K, Messiou C. Otero S, et al. Among authors: thway k. Clin Radiol. 2015 Sep;70(9):1038-45. doi: 10.1016/j.crad.2015.04.015. Epub 2015 Jul 7. Clin Radiol. 2015. PMID: 26162574 Review.

9

SMARCA4-Deficient Thoracic Sarcoma.

Foot O, Hallin M, Jones RL, Thway K. Foot O, et al. Among authors: thway k. Int J Surg Pathol. 2021 Sep;29(6):640-641. doi: 10.1177/1066896920938134. Epub 2020 Jul 1. Int J Surg Pathol. 2021. PMID: 32608292 No abstract available.

10

EWSR1-SMAD3-Positive Fibroblastic Tumor.

Foot O, Hallin M, Jones RL, Sumathi VP, Thway K. Foot O, et al. Among authors: thway k. Int J Surg Pathol. 2021 Apr;29(2):179-181. doi: 10.1177/1066896920938124. Epub 2020 Jul 3. Int J Surg Pathol. 2021. PMID: 32615834

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results